These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 683426)

  • 41. Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
    Bonkovsky HL; Healey JF; Lourie AN; Gerron GG
    Am J Gastroenterol; 1991 Aug; 86(8):1050-6. PubMed ID: 1713408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Afro-Americans and acute intermittent porphyria (AIP).
    Kreimer-Birnbaum M; Bannerman RM; El-Khatib M; Franco-Saenz R
    Int J Biochem; 1980; 12(5-6):795-9. PubMed ID: 7450135
    [No Abstract]   [Full Text] [Related]  

  • 43. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Porphyria variegata (author's transl)].
    Hofmann C; Schmidt D; Braun-Falco O
    MMW Munch Med Wochenschr; 1975 Dec; 117(50):1969-74. PubMed ID: 814414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of acute porphyria.
    Yeung Laiwah AC; Moore MR; Goldberg A
    Q J Med; 1987 May; 63(241):377-92. PubMed ID: 3310073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Social problems of porphyria].
    Tarczyńska-Nosal S; Kostrzewska E
    Pol Merkur Lekarski; 1998 Mar; 4(21):147-9. PubMed ID: 9640067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitation of 3-ethyl-5-hydroxy-4,5-dimethyl-delta 3-pyrrolin-2-one in the urine of patients with acute intermittent porphyria.
    Graham DJ; Brodie MJ; McColl KE; Moore MR; Goldberg A
    Eur J Clin Invest; 1979 Feb; 9(1):49-53. PubMed ID: 110600
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Polyneuropathy in acute intermittent porphyria].
    Szela S; Gogolewska I; Pliszka M; Was B
    Wiad Lek; 1989 Jul 1-15; 42(13-15):888-90. PubMed ID: 2634316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute intermittent porphyria--a clinical review].
    Lithner F
    Lakartidningen; 1979 Dec; 76(52):4798-4801. PubMed ID: 545005
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)].
    Brugsch J; Müller H
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical and laboratory findings concerning at first dietary and afterwards cimetidine treatment of acute intermittent porphyria].
    Gullotti D; Schillaci L; Amato S; Salerno L
    Clin Ter; 1994 Aug; 145(8):123-9. PubMed ID: 7955957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurological and neuropsychiatric manifestations of porphyria.
    Suh Y; Gandhi J; Seyam O; Jiang W; Joshi G; Smith NL; Ali Khan S
    Int J Neurosci; 2019 Dec; 129(12):1226-1233. PubMed ID: 31402774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical usefulness of cimetidine treatment for acute relapse in intermittent porphyria.
    Horie Y; Norimoto M; Tajima F; Sasaki H; Nanba E; Kawasaki H
    Clin Chim Acta; 1995 Jan; 234(1-2):171-5. PubMed ID: 7758217
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of acute porphyric attacks by intravenous haematin.
    Lamon JM; Frykholm BC; Bennett M; Tschudy DP
    Lancet; 1978 Sep; 2(8088):492-4. PubMed ID: 79864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of transcutaneous nerve stimulation in the attacks of acute intermittent porphyria.
    Kaada B; Romslo I
    Int J Biochem; 1985; 17(2):235-40. PubMed ID: 3874101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute intermittent porphyria in Poland.
    Darocha T; Gregor A
    S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281
    [No Abstract]   [Full Text] [Related]  

  • 59. [Porphyrias. Considerations apropos of 26 cases].
    Marchiori PE; Scaff M; de Camargo E; Moraes F; Bacheschi LA; de Assis JL
    Rev Hosp Clin Fac Med Sao Paulo; 1982 Jun; 37(3):101-7. PubMed ID: 7146752
    [No Abstract]   [Full Text] [Related]  

  • 60. Elevated porphyrins following propofol anaesthesia in acute intermittent porphyria.
    Elcock D; Norris A
    Anaesthesia; 1994 Nov; 49(11):957-8. PubMed ID: 7802240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.